Psychedelics: a new age for mental health?

This webinar has now taken place, but please complete our form if you would like to be sent a copy of the recording.

We are delighted to be hosting our first life sciences webinar of 2023 on Tuesday 28 February.

This interactive discussion will consider the renewed interest in the use and regulation of psychedelics - a class of psychoactive substances that produce changes in perception, mood and cognitive processes – which many life sciences stakeholders believe could be the solution to the global mental health crisis.

Nathalie Smyth, Legal Director in our products law and life sciences team will be joined by the eminent Professor David Nutt, Director of the Neuropsychopharmacology Unit in the Division of Brain Sciences at Imperial College London, who will consider:

• An overview of the history and use of psychedelics.
• The status of clinical trials research and outcomes.
• Current legal restrictions and proposed safeguards.
• Potential risks and liabilities.

This webinar is relevant to stakeholders across the life sciences industry, including manufacturers, suppliers, importers and exporters, healthcare professionals, in-house counsel, insurers, claims managers and underwriters.